Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - OPERATING INCOME
Operating Income ITCI - Intra-Cellular Therapies, Inc.
-159 M
LAST VALUE
25.31%
2 YEAR CAGR
0.36%
5 YEAR CAGR
-19.76%
10 YEAR CAGR